The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of treatment approaches in patients with advance penile cancer: An analysis from a nationwide study.
 
Mohammad Arfat Ganiyani
No Relationships to Disclose
 
Atulya Aman Khosla
No Relationships to Disclose
 
Shahzaib Ahmad
No Relationships to Disclose
 
Karan Jatwani
No Relationships to Disclose
 
Muni Rubens
No Relationships to Disclose
 
Mukesh Roy
No Relationships to Disclose
 
Bruno R. Bastos
Consulting or Advisory Role - AstraZeneca; AVEO; Bayer; Dendreon; Epizyme; Genzyme; Janssen Oncology; Lilly; Regeneron
Speakers' Bureau - Exelixis; Pfizer/Myovant; Sanofi/Regeneron; Seattle Genetics/Astellas
Research Funding - Actuate Therapeutics (Inst); Altor BioScience (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Nektar (Inst); Tempest Therapeutics (Inst); Tolero Pharmaceuticals (Inst); US Oncology (Inst)
 
Manuel Ozambela
Travel, Accommodations, Expenses - Intuitive Surgical
 
Ahmed Eldefrawy
No Relationships to Disclose
 
Murugesan Manoharan
No Relationships to Disclose
 
Rohan Garje
Research Funding - Amgen (Inst); Endocyte/Advanced Accelerator Applications (Inst); Immunomedics (Inst); Pfizer (Inst); xencor (Inst)